Literature DB >> 21718850

Impact of laterality on early and late survival after pneumonectomy.

Felix G Fernandez1, Seth D Force, Allan Pickens, Patrick D Kilgo, Theresa Luu, Daniel L Miller.   

Abstract

BACKGROUND: This study evaluated the effect of laterality on survival in patients who underwent pneumonectomy for lung cancer.
METHODS: We reviewed the Surveillance, Epidemiology, and End Results (SEER) database for patients who underwent pneumonectomy for lung cancer from 1988 through 2006. Predictors of survival were determined by univariate and multivariable analysis.
RESULTS: A total of 9746 patients had pneumonectomies. Left pneumonectomies (56%) were more common than right; 67% of patients were men with mean age of 63 years (range, 12 to 92 years). Tumor pathology was squamous cell in 49% and adenocarcinoma in 34%. Stage distribution was stage I, 28%; stage II, 28%; stage IIIA, 19%; stage IIIB, 18%; and stage IV, 6%. Overall survival was 67% and 40%, respectively, at 1 and 3 years; with 63% and 39% for right vs 70% and 41% for left (p<0.001). Mortality at 1 and 3 months was 8% and 16% for right pneumonectomies and 4% and 9% for left (p<0.001). Multivariate predictors of worse survival were right pneumonectomy, age, stage, male sex, tumor size, grade, prior malignancy, not married, number of positive lymph nodes, and fewer lymph nodes evaluated (all p<0.05). The adjusted hazard ratio for right pneumonectomy was 1.12 (95% confidence interval, 1.07 to 1.18; p<0.00001). For 3-month survival, right pneumonectomy had an adjusted odds ratio of 2.01 (95% confidence interval, 1.77 to 2.29; p<0.001). Neoadjuvant radiotherapy did not affect 3-month survival (adjusted odds ratio, 0.88; 95% confidence interval, 0.1 to 7.03, p=0.9).
CONCLUSIONS: A right pneumonectomy is associated with approximately twice the perioperative mortality as a left pneumonectomy. However, neoadjuvant radiotherapy does not appear to add incremental risk, and long-term survival is not affected by laterality.
Copyright © 2011 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21718850     DOI: 10.1016/j.athoracsur.2011.03.021

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  17 in total

1.  Nonclinical Factors Associated with 30-Day Mortality after Lung Cancer Resection: An Analysis of 215,000 Patients Using the National Cancer Data Base.

Authors:  John N Melvan; Manu S Sancheti; Theresa Gillespie; Dana C Nickleach; Yuan Liu; Kristin Higgins; Suresh Ramalingam; Joseph Lipscomb; Felix G Fernandez
Journal:  J Am Coll Surg       Date:  2015-04-16       Impact factor: 6.113

2.  Survival in the elderly after pneumonectomy for early-stage non-small cell lung cancer: a comparison with nonoperative management.

Authors:  Paul J Speicher; Asvin M Ganapathi; Brian R Englum; Mark W Onaitis; Thomas A D'Amico; Mark F Berry
Journal:  J Am Coll Surg       Date:  2013-12-12       Impact factor: 6.113

3.  Pneumonectomy for node-positive non-small cell lung cancer: can it be a treatment option for N2 disease?

Authors:  Satona Tanaka; Minoru Aoki; Hiroyuki Ishikawa; Yosuke Otake
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-03-01

4.  The Society of Thoracic Surgeons Lung Cancer Resection Risk Model: Higher Quality Data and Superior Outcomes.

Authors:  Felix G Fernandez; Andrzej S Kosinski; William Burfeind; Bernard Park; Malcolm M DeCamp; Christopher Seder; Blair Marshall; Mitchell J Magee; Cameron D Wright; Benjamin D Kozower
Journal:  Ann Thorac Surg       Date:  2016-05-19       Impact factor: 4.330

5.  Pneumonectomy for Clinical Stage IIIA Non-Small Cell Lung Cancer: The Effect of Neoadjuvant Therapy.

Authors:  Stephen R Broderick; Aalok P Patel; Traves D Crabtree; Jennifer M Bell; Daniel Morgansztern; Clifford G Robinson; Daniel Kreisel; A Sasha Krupnick; G Alexander Patterson; Bryan F Meyers; Varun Puri
Journal:  Ann Thorac Surg       Date:  2015-09-26       Impact factor: 4.330

6.  Classify multicategory outcome in patients with lung adenocarcinoma using clinical, transcriptomic and clinico-transcriptomic data: machine learning versus multinomial models.

Authors:  Fei Deng; Lanlan Shen; He Wang; Lanjing Zhang
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

7.  Preliminary results of tomotherapy for treatment of inoperable recurrent non-small cell lung cancer at bronchial stump site after right pneumonectomy.

Authors:  Hong Seok Jang; Seong Kwon Moon
Journal:  Contemp Oncol (Pozn)       Date:  2015-01-12

8.  Pneumonectomy for Clinical Stage I Non-Small Cell Lung Cancer in Elderly Patients over 70 Years of Age.

Authors:  Tae Ho Kim; Byungjoon Park; Jong Ho Cho; Hong Kwan Kim; Yong Soo Choi; Kwhan-Mien Kim; Young Mog Shim; Jaeil Zo; Jhingook Kim
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2015-08-05

9.  Development and validation of a risk score for predicting death after pneumonectomy.

Authors:  Seyer Safi; Axel Benner; Janos Walloschek; Maria Renner; Jan op den Winkel; Thomas Muley; Konstantina Storz; Hendrik Dienemann; Hans Hoffmann; Thomas Schneider
Journal:  PLoS One       Date:  2015-04-09       Impact factor: 3.240

10.  Comprehensive study of prognostic risk factors of patients underwent pneumonectomy.

Authors:  Chang Gu; Rui Wang; Xufeng Pan; Qingyuan Huang; Jizhuang Luo; Jiajie Zheng; Yiyang Wang; Jianxin Shi; Haiquan Chen
Journal:  J Cancer       Date:  2017-07-05       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.